Showing results (2451-2460 of 2,729) with videos related to

Sort By:
Pageof 273
Thoracic Cancer|December 5, 2018
Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational studyXinchun Duan, Yujie Zhu, Yong Cui, et al.
BMC Palliative Care|June 23, 2021
Adapting ENABLE for patients with advanced cancer and their family caregivers in Singapore: a qualitative formative evaluationGrace Meijuan Yang, J Nicholas Dionne-Odom, Yi Han Foo, et al.
Molecular Neurobiology|May 24, 2014
Reducing effect of IL-32α in the development of stroke through blocking of NF-κB, but enhancement of STAT3 pathwaysChul Ju Hwang, Hyung-Mun Yun, Yu Yeon Jung, et al.
Protein & Cell|March 15, 2023
A YAP/TAZ-CD54 axis is required for CXCR2-CD44- tumor-specific neutrophils to suppress gastric cancerPingping Nie, Weihong Zhang, Yan Meng, et al.
Neurosurgical Review|January 29, 2026
Identifying four distinct prognostic trajectories using latent class growth analysis in moderate-severe TBI: a 10-year retrospective cohort studyRen-Ci Wang, Jing Yan, Jun-Jie Zhao, et al.
European Journal of Preventive Cardiology|November 2, 2016
Utility of genetic and non-genetic risk factors in predicting coronary heart disease in Singaporean ChineseXuling Chang, Agus Salim, Rajkumar Dorajoo, et al.
The Journal of Clinical Investigation|May 7, 2024
Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injuryYuan Gui, Haiyan Fu, Zachary Palanza, et al.
Medcomm|June 18, 2026
A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell CarcinomaMingming Hu, Shuku Liu, Yi Han, et al.
Journal of Gastroenterology and Hepatology|July 5, 2014
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infectionRichard A Colvin, Tawesak Tanwandee, Teerha Piratvisuth, et al.
Neuropharmacology|July 30, 2013
Inhibitory effect of a 2,4-bis(4-hydroxyphenyl)-2-butenal diacetate on neuro-inflammatory reactions via inhibition of STAT1 and STAT3 activation in cultured astrocytes and microglial BV-2 cellsJin A Kim, Hyung-Mun Yun, Peng Jin, et al.
Pageof 273